ong QT syndrome (LQTS) is a rare disease characterized by prolonged ventricular repolarization and a high risk for cardiac events including sudden cardiac death. 1 Mutations causing LQTS have been identified in 5 genes, each encoding a cardiac ion channel and its regulatory subunit. [2] [3] [4] [5] Most cases of LQTS that come to the attention of physicians are either symptomatic or familial. [6] [7] [8] Recent studies have reported that life-threatening arrhythmias in LQTS patients tend to occur under specific circumstances (eg, exercise, emotion, and sleep/rest without arousal) in a gene-specific manner. 9 Beta-blocker therapy is reported to be effective in preventing LQTS-related cardiac events in these patients, but they continue to occur while patients are on the prescribed medication. 10 A recent report has reported a gender reference in the electrocardiographic (ECG) response to -blockers in patients with LQTS. 11 A screening program conducted for Japanese children (1st, 7th and 10th grades) has uncovered large numbers of children with LQTS both without a family history and without a history of LQTS-related cardiac events at the Circulation Journal Vol.67, December 2003 time of diagnosis. 12-14 The initiation of drug therapy for these young patients is controversial because many pediatric cardiologists consider that few young LQTS patients without a past history have experienced new cardiac events after diagnosis. The objective of the present study, then, was to examine the characteristics of Japanese pediatric patients with LQTS and to determine the predictive factors for cardiac events after diagnosis in these young patients with and without a past history of cardiac events.
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Methods

Subjects and Data
A questionnaire was sent to 111 hospitals where the trustee(s) of the Japanese Society of Pediatric Cardiology and Cardiac Surgery were working. Subjects were those who visited one of those hospitals from January 1997 to August 2000 and who were less than 20 years old at the time of diagnosis. Characteristics of the subjects obtained from the survey included the following: past history of LQTS-related cardiac events, ECG findings, clinical and family history for diagnosis of LQTS according to the criteria of Schwartz et al, 15 cardiac events during the period after diagnosis and medication. When medication was prescribed, those patients were re-surveyed for compliance. Subjects were classified into 2 groups on the basis of the presence or absence of a past history of LQTS-related cardiac events at the time of diagnosis. The index events for diagnosis were classified as follows: (1) because of symptoms (symptomatic group), (3) visiting because of family history (familial group), and (4) diagnosed by chance (incidental group).
LQTS-related cardiac events include unexplained syncope, drowning or near-drowning, and unexplained sudden death. Noncompliance with medication was defined as not taking the prescribed medicine for more than 2 days during the follow-up period.
Measurement of the QT Interval
An ECG at the time of diagnosis or during the follow-up period was requested. Three consecutive QT and RR intervals in lead V5 for each child were measured by one of the authors (MY), and the mean QTc values (QT interval corrected by Bazett formula) were calculated. The intraleader coefficient of variability of the mean QT interval was 1.7%. The QT interval was measured from the onset of the Q wave to the end of the T wave in lead V5. Bifid T waves, but not U waves, were included in the QT measurement.
Inclusion Criteria
The diagnostic criteria for LQTS were those of Schwartz et al: 15 ≤1 point: low probability of LQTS; 2 or 3 points: intermediate probability of LQTS; and ≥4 points: high probability of (or definite) LQTS. The inclusion criteria were as follows: (1) subjects for whom complete information and an ECG could be obtained, (2) a LQTS score of more than 0, and (3) subjects who had been followed for more than 12 months. Exclusion criteria were drugs and/or conditions that prolong the QT interval.
Statistical Analysis
The data were expressed as the mean ± 1SD. Differences in incidence between groups were analyzed by Fisher's exact probability test. Differences in mean values between the groups were analyzed using the Mann-Whitney U test.
To determine the predictive factors for LQTS-related cardiac events after the diagnosis of LQTS in each group with or without previous cardiac events, stepwise regression analyses were carried out. The first, a univariate regression analysis was performed using the appearance of the LQTSrelated cardiac event since diagnosis as a dependent variable and selected parameters as independent variables. The parameters used in the analyses were: age at the initial diagnosis, sex, the mean QTc values, presence or absence of each diagnostic criterion of Schwartz 16 (T-wave alternans, notched T wave in 3 leads, low heart rate for age, congenital deafness, family history with definite LQTS, and family history of unexplained sudden cardiac death), total LQTS score, presence or absence of -blocker therapy, and compliance or noncompliance with medication. In the stepwise regression analysis, the appearance of the LQTS-related cardiac events since diagnosis was used as a dependent variable, and the parameters that showed a significant relation with the appearance of the cardiac events by the univariate regression analysis as the independent variables.
Positive predictive values of noncompliance with medication for the group with a past history of LQTS-related cardiac events and a negative predictive value of the total LQTS score for the group without a past history were also determined. A p-value <0.05 was considered statistically significant.
Results
Clinical Characteristics All Subjects
We collected 231 cases from 36 (32.4%) of the 111 hospitals and of those, 197 fulfilled the inclusion criteria (Table 1) . No difference was found in age at diagnosis or the mean QTc values between patients with and without a past history of LQTS-related cardiac events. The mean observation period after diagnosis of the patients with a past history was significantly longer than that of those without a past history (p<0.0001). The appearance of LQTS-related cardiac events after diagnosis was significantly higher in the patients with a past history (47%) than in those without (5%) (p<0.0001). All 5 patients who died suddenly had a past history of cardiac events. In the group without a past history, there were 3 cases of noncompliance with medication; in the group with a past history, there were 12 such cases of which 11 had a recurrence of LQTSrelated cardiac events and there were 4 cases of sudden death. 
Subjects Who had No Symptoms Before Diagnosis Classified by the Index Event of Diagnosis
Of the 129 patients who did not have a past history of cardiac events, 108 were screened by the program; the remaining 21 patients were diagnosed by a family study (13 patients) , by chance (5 patients), and by unknown means (3 patients). The incidental group was diagnosed during the follow-up periods of other diseases (Kawasaki disease, ventricular septal defect, atrial septal defect, and fetal arrhythmia) or at the initial consultation for functional murmur. The index events of diagnosis of 3 patients were unknown because they came from other institutions or doctors. The age at diagnosis of the patients who were screened was significantly higher than that of the patients diagnosed by other means ( Table 2 ). The mean QTc value in the screened group was significantly longer than that in the other patients.
Subjects Who had Symptoms Before Diagnosis Classified by the Index Event of Diagnosis
Of the 68 patients who had a past history of cardiac events, 40 had visited hospital because of symptoms, 18 were screened by the program, 5 were diagnosed during a family study, and 2 were incidental (fetal arrhythmia and during recording of an electroencephalogram). Three patients' events were unknown. The age at diagnosis of the screened patients was higher than that of patients diagnosed by other means (Table 3 ). All patients who were screened by the program had a prolonged QT interval equal to or more than 0.47 s 1/2 . In 10 patients who were diagnosed by other means the interval between the time of diagnosis and the recurrence of a new episode after diagnosis was shorter than that in the 7 patients who were screened, although the difference was not significant.
Subjects With a Family History of LQTS and/or Sudden Cardiac Death and Subjects With Sporadic Occurrence
The age at diagnosis was significantly lower and the observation period significantly longer in patients with a family history than those with sporadic occurrence (Table 4 ). The incidence of symptoms both before and after diagnosis was significantly higher in the patients with a family history. In the 90 cases of sporadic occurrence that had been screened and did not have symptoms even after diagnosis, -blocker had been prescribed in 6 cases.
Predictive Factors for LQTS-Related Cardiac Events During Follow-up
To determine the predictive factors for LQTS-related cardiac events during the observation period after diagno- sis, univariate regression analyses between the appearance of the LQTS-related cardiac event after diagnosis and the selected parameters were performed (Table 5 ). Next, stepwise analyses using these significant parameters as the independent variables were carried out. The analyses showed that noncompliance with medication and a lower age at diagnosis were significant predictors in the group with a past history of cardiac events and that the total LQTS score was a predictive factor in the group without a past history (Table 6 ).
Positive and Negative Predictive Values
The positive predictive value of noncompliance with medication for predicting a LQTS-related cardiac event after diagnosis was 79% in the group with a past history of cardiac events. The negative predictive value of the total LQTS score <4 points was 100% in the group without a past history of the cardiac events (Table 7) .
Effectiveness of Beta-Blockers in Preventing Recurrence of LQTS-Related Cardiac Events
The incidence of recurrence of cardiac events was significantly lower in patients taking -blocker medication than that in untreated patients in the group with a past history of cardiac events (p=0.0016, Table 1 ).
Discussion
The present study showed that the significant factors for predicting LQTS-related cardiac events in patients with a past history were noncompliance with medication and a lower age at diagnosis. The total LQTS score was a predictive factor in the group without a past history of LQTScardiac events.
It is well known that LQTS-related cardiac events recur and mortality continues unabated. 16 In the group with a past history of the cardiac events, 35% of the patients experienced recurrent symptoms while on -blocker medication (Table 1) , which was a similar incidence to that reported from a large-scale study showing that 32% of patients had recurrent symptoms or died within 5 years while onblockers. 10 That same study also showed that patients with a lower age had a higher hazard ratio of the risk of experiencing a cardiac event during the observation period, and that the cumulated probability of cardiac events after initiation of -blockers in patients with a past history of cardiac events increased progressively during the observation period. 10 In the present study, -blocker therapy prevented recurrence of cardiac events in the group with a past history of cardiac events (Table 1) ; however, the lack of a dosedependent effect or resistance to -blockers has been reported, 10, 17 indicating the need for further study.
One of the important findings in the present study is that noncompliance with medication is a significant predictor for recurrence of LQTS-related cardiac events. Noncompliance has been suspected as one of the reasons for the ineffectiveness of -blockers in some patients, 10 but there had not been confirmative data. Improving the compliance of patients and their parents with the therapeutic regimen will be necessary to prevent LQTS-related cardiac events. The mean QTc value in the patients diagnosed by means other than the screening program was significantly shorter than that in the screened group ( Table 2 ). The reasons may be a younger age at diagnosis than those in the screened group, and because some patients diagnosed by family study had a shorter QTc value. Nevertheless, the finding suggests that we need to further determine risk factors other than the QTc value in nonscreened patients.
The total LQTS score was created to establish the diagnosis of LQTS syndrome. 15, 16 In the group without a past history of cardiac events, the total LQTS score was a predictive factor; in fact, the negative predictive value of the total LQTS score <4 points was 100%. We have to further determine precise predictive factors to predict LQTSrelated cardiac events after diagnosis in patients a without past history, because this group has a low occurrence of events.
In conclusion, compliance with medication must be improved in the group with a past history. For the group without cardiac events, the negative predictive value of the total LQTS score was 100%, and other positive predictive factor(s) need to be established. 
